Operating Expenses Lave om Dato
AbbVie USD 11.11B 540M 2023-12
Aceragen USD 23.08M 14.13M 2023-03
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Galectin Therapeutics USD 9.17M 163K 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Immunic USD 23.57M 1.45M 2023-09
Incyte USD 826.07M 121.75M 2023-12
Merck USD 16.56B 6.35B 2023-12
Regulus Therapeutics USD 8.12M 810K 2023-09



Galectin Therapeutics Driftsomkostninger - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.